Compare LOCL & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LOCL | BEAT |
|---|---|---|
| Founded | 2021 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.9M | 23.9M |
| IPO Year | 2021 | 2021 |
| Metric | LOCL | BEAT |
|---|---|---|
| Price | $0.92 | $0.54 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 16.3K | ★ 16.3M |
| Earning Date | 11-11-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.33 | 15.07 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $48,365,000.00 | N/A |
| Revenue This Year | $93.32 | N/A |
| Revenue Next Year | $25.13 | $1,197.12 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 26.82 | N/A |
| 52 Week Low | $0.90 | $0.36 |
| 52 Week High | $3.13 | $4.00 |
| Indicator | LOCL | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 39.23 | 62.01 |
| Support Level | N/A | $0.49 |
| Resistance Level | $1.20 | $0.63 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 17.24 | 83.06 |
Local Bounti Corp is a controlled environment agriculture company. The business model is based on building local facilities, operated by local teams, to deliver fresh and quality produce to local communities while maintaining a limited carbon footprint. Using proprietary technology to grow leafy greens and herbs in smart greenhouses with a cultivation process that uses less water and land than conventional agriculture, free from herbicides or pesticides. The products of the company include living lettuce, leafy greens, herbs, and others.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.